Core Viewpoint - The acquisition plan by Yiyi Co., Ltd. to purchase 100% equity of Hangzhou Gaoye Family Pet Food Co., Ltd. has been terminated due to discrepancies between the actual operating conditions of Gaoye Family and initial expectations [2][3] Group 1: Acquisition Termination - Yiyi Co. announced the termination of the acquisition after nearly four months of planning, citing that Gaoye Family's operational performance during the 2025 "Double Eleven" event and subsequent product launches did not align with initial expectations [2][3] - The decision to terminate the acquisition was made after careful consideration and discussions with all parties involved, ensuring that it would not adversely affect Yiyi Co.'s operations or financial status [3][4] Group 2: Company Strategy and Future Plans - Yiyi Co. will continue to focus on its core business of pet hygiene products and will not alter its strategic deployment in the domestic market despite the acquisition's termination [4][6] - The company plans to maintain communication with Gaoye Family and will pursue a dual-circulation strategy involving both domestic and overseas markets, as well as continue investments in pet health and smart products [4][6] Group 3: Financial Performance and Market Position - In the first three quarters of 2025, Yiyi Co. reported revenues of 1.306 billion yuan, a slight decline of 0.72% year-on-year, while net profit attributable to shareholders was 156 million yuan, an increase of 3.82% [8] - The pet food sector accounted for 53.7% of the market share in 2025, highlighting the importance of this segment for Yiyi Co.'s growth strategy [8][9] Group 4: Future Collaboration Possibilities - Although the acquisition did not proceed, both Yiyi Co. and Gaoye Family expressed a willingness to explore future collaborations in product development and brand operations [7][9] - Yiyi Co. remains an indirect shareholder of Gaoye Family, which may facilitate ongoing partnerships despite the failed acquisition [7]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a strong performance relative to the market [7]. Core Insights - The company reported its 2025 mid-year results, which met expectations, with a revenue of 888 million yuan for H1 2025, reflecting a year-on-year increase of 9.3%. The net profit attributable to the parent company was 102 million yuan, up 7.4% year-on-year [7]. - The impact of tariffs on revenue was significant in Q2 2025, but recovery is expected as orders gradually resume. The company has a strong market position, with its pet hygiene products accounting for over 30% of the domestic customs export volume in the same category [7]. - Profitability improved due to declining raw material prices, with a gross margin of 19.1% in Q2 2025, up 0.3 percentage points quarter-on-quarter. The net profit margin also showed resilience, increasing to 11.9% in Q2 2025 [7]. - The company is confident in its future growth, as evidenced by employee stock ownership plans, share buybacks, and insider purchases, which align the interests of management and employees with the company's performance [7]. - The global pet industry is experiencing growth, and the company is well-positioned in the pet hygiene product segment, benefiting from a recovery in raw material prices and increased production capacity [7]. Financial Summary - Total revenue is projected to grow from 1,798 million yuan in 2024 to 1,980 million yuan in 2025, with a year-on-year growth rate of 10.2% [3]. - The net profit attributable to the parent company is expected to increase from 215 million yuan in 2024 to 238 million yuan in 2025, reflecting a growth rate of 10.6% [3]. - The earnings per share (EPS) is forecasted to rise from 1.18 yuan in 2024 to 1.29 yuan in 2025 [3].